Pathogen: clinical or host-associated sample from ... - BioSample - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

Result Filters

Pathogen: clinical or host-associated sample from Escherichia coli

Identifiers: BioSample: SAMN36729118; Sample name: BWH_300_E_col; SRA: SRS18433650

Organism: Escherichia coli
cellular organisms; Bacteria; Pseudomonadota; Gammaproteobacteria; Enterobacterales; Enterobacteriaceae; Escherichia

Package: Pathogen: clinical or host-associated; version 1.0

Attributes

isolate	BWH_300_E_col
collected by	Brigham and Women's Hospital
collection date	2022
geographic location	USA:Boston
host	Homo sapiens
host disease	Urinary tract infection
isolation source	urine
latitude and longitude	42.3362 N 71.1067 W
host age	57

BioProject: PRJNA278886
Retrieve all samples from this project

Submission: Brigham and Women's Hospital, Jay Worley; 2023-07-27

Antibiogram
Antibiotic	Resistance phenotype	Measurement sign	Measurement	Measurement units	Laboratory typing method	Laboratory typing platform	Vendor	Laboratory typing method version or reagent	Testing standard
amikacin	susceptible	<=	2	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
amoxicillin-clavulanic acid	susceptible	<=	2/1	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
ampicillin	resistant	>=	32	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
cefazolin	susceptible	<=	4	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
cefepime	susceptible	<=	1	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
cefoxitin	susceptible	<=	4	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
ceftazidime	susceptible	<=	1	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
ceftriaxone	susceptible	<=	1	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
ciprofloxacin	susceptible	<=	0.25	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
ertapenem	susceptible	<=	0.5	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
gentamicin	susceptible	<=	1	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
levofloxacin	susceptible	<=	0.12	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
meropenem	susceptible	<=	0.25	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
nitrofurantoin	intermediate	==	64.0	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
piperacillin-tazobactam	susceptible	<=	4/4	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
tetracycline	susceptible	<=	1	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
tobramycin	susceptible	<=	1	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
trimethoprim-sulfamethoxazole	susceptible	<=	1/19	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI

Accession:: SAMN36729118
ID:: 36729118

BioProject SRA Nucleotide

Supplemental Content

Related information

BioProject
BioProject links
SRA
Links to SRA experiments
Nucleotide
Nucleotide links
Assembly
Assembly

Recent activity

Clear Turn Off Turn On

Pathogen: clinical or host-associated sample from Escherichia coli
Pathogen: clinical or host-associated sample from Escherichia coli

biosample
Pathogen: clinical or host-associated sample from Clostridioides difficile
Pathogen: clinical or host-associated sample from Clostridioides difficile

biosample
Pathogen: clinical or host-associated sample from Serratia marcescens
Pathogen: clinical or host-associated sample from Serratia marcescens

biosample
Pathogen: clinical or host-associated sample from Klebsiella pneumoniae
Pathogen: clinical or host-associated sample from Klebsiella pneumoniae

biosample

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

You are here: NCBI > DNA & RNA > BioSample